In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Pfizer brand of exemestane Drug Master File in Korea (Pfizer brand of exemestane KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Pfizer brand of exemestane. The MFDS reviews the Pfizer brand of exemestane KDMF as part of the drug registration process and uses the information provided in the Pfizer brand of exemestane KDMF to evaluate the safety and efficacy of the drug.
After submitting a Pfizer brand of exemestane KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Pfizer brand of exemestane API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Pfizer brand of exemestane suppliers with KDMF on PharmaCompass.